Literature DB >> 3262044

Excretion of mefloquine in human breast milk.

M D Edstein1, J R Veenendaal, R Hyslop.   

Abstract

Concentrations of mefloquine in plasma and breast milk were measured in 2 women following the administration of one Lariam tablet (250 mg mefloquine). The milk-to-plasma ratio of mefloquine based on the area under the plasma and milk concentration curves was 0.13 and 0.16. After a maternal mefloquine dose of 3.73 mg/kg and assuming a daily milk ingestion of 1 litre over a week, the maximum amount of drug ingested by an infant would be 0.14 mg/kg. During lactation the plasma clearance and apparent volume of distribution of mefloquine were about 50% less than the same parameters calculated after lactation had ceased.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262044     DOI: 10.1159/000238566

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

1.  Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.

Authors:  E J Begg; H C Atkinson; S B Duffull
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  STATEMENT ON PREGNANCY AND TRAVEL: Committee to Advise on Tropical Medicine and Travel.

Authors:  C Beallor
Journal:  Can Commun Dis Rep       Date:  2010-03-08

Review 3.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 5.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.